Skip to main content

Market Overview

IBM Contemplates Watson Health Business Divestment To Focus On Cloud: WSJ

Share:
  • International Business Machines Corp. (NYSE: IBM) is contemplating the divestment of its IBM Watson Health business to focus on its core cloud computing business, the Wall Street Journal reports.
  • The company is exploring options, including its sale to a private-equity firm sale or industry player or a merger with a blank-check company.
  • IBM has to catch up to its cloud computing peers like Microsoft Corporation (NASDAQ: MSFT) and Amazon.com Inc (NASDAQ: AMZN), which are already in the trillion-dollar valuation club.
  • Watson Health employs artificial intelligence (AI) to assist hospitals, insurers, and drug makers for data management with $1 billion in annual revenue, and it is not yet profitable. Its popular brands include Merge Healthcare, Phytel, and Truven Health Analytics.
  • WSJ notes that the valuation isn't clear yet, and there may not be a sale.
  • Watson was one of IBM's significant initiatives in recent years, as the company made billon dollar bets in acquiring health-related businesses that are now part of IBM Watson Health. 
  • With physicians hesitant to adopt AI, Watson Health's results have been less pleasing than IBM anticipated.
  • Price action: IBM shares were up 0.64% at $121.50 in the pre-market session on the last check Friday.
 

Related Articles (IBM)

View Comments and Join the Discussion!

Posted-In: Watson 2.0News Asset Sales Tech Media

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com